Status:

COMPLETED

Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.

Lead Sponsor:

Istituto Ortopedico Rizzoli

Conditions:

Anemia (Diagnosis)

Iron-deficiency

Eligibility:

All Genders

18+ years

Brief Summary

Retrospective observational study: impact of a peri-operative patient blood management program (PBM) on transfusion rates of patients undergoing elective hip replacement.

Detailed Description

A Patient Blood Management (PBM) program was implemented in year 2019 in our institution: patient scheduled for elective total hip replacement underwent pre-operative screening about one month before ...

Eligibility Criteria

Inclusion

  • undergoing elective hip replacement in the selected time-frame
  • American Society of Anesthesiology (ASA) status 1-2-3
  • age \>18

Exclusion

  • patients not undergoing screening as outpatients at pre-operative clinic

Key Trial Info

Start Date :

August 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 4 2023

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT04398238

Start Date

August 1 2021

End Date

April 4 2023

Last Update

May 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sandra Giannone

Bologna, BO, Italy, 40128

Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program. | DecenTrialz